Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RxSight (RXST) Cash from Operations (2020 - 2025)

RxSight (RXST) has disclosed Cash from Operations for 6 consecutive years, with 1116000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Operations rose 73.8% year-over-year to 1116000.0, compared with a TTM value of 15511000.0 through Dec 2025, up 8.47%, and an annual FY2025 reading of 15511000.0, up 8.47% over the prior year.
  • Cash from Operations was 1116000.0 for Q4 2025 at RxSight, up from 1187000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 650000.0 in Q3 2024 and bottomed at 17764000.0 in Q1 2023.
  • Average Cash from Operations over 5 years is 8880400.0, with a median of 8777000.0 recorded in 2021.
  • The sharpest move saw Cash from Operations skyrocketed 108.14% in 2024, then tumbled 282.62% in 2025.
  • Year by year, Cash from Operations stood at 8722000.0 in 2021, then tumbled by 58.84% to 13854000.0 in 2022, then soared by 40.08% to 8301000.0 in 2023, then soared by 48.68% to 4260000.0 in 2024, then surged by 73.8% to 1116000.0 in 2025.
  • Business Quant data shows Cash from Operations for RXST at 1116000.0 in Q4 2025, 1187000.0 in Q3 2025, and 4376000.0 in Q2 2025.